Pregled bibliografske jedinice broj: 307257
Secondary prevention of coronary heart disease in county hospital.
Secondary prevention of coronary heart disease in county hospital. // Atherosclerosis Supplements, Volume 7, Issue 3 / Schaefer, EJ ; Shepherd J (ur.).
Rim, Italija: Elsevier, 2006. str. 118-118 (poster, međunarodna recenzija, sažetak, stručni)
CROSBI ID: 307257 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Secondary prevention of coronary heart disease in county hospital.
Autori
Ivanuša, Mario
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, stručni
Izvornik
Atherosclerosis Supplements, Volume 7, Issue 3
/ Schaefer, EJ ; Shepherd J - : Elsevier, 2006, 118-118
Skup
XIV International Symposium on Atherosclerosis
Mjesto i datum
Rim, Italija, 18.06.2006. - 22.06.2006
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
coronary heart disease; risk factors; treatment
Sažetak
Objective: To make comparison between the use of cardiovascular medications in coronary heart disease (CHD) patients at the time of discharge. Methods: From 1998 to 2003 patients treated for CHD at the Department of Internal Medicine Bjelovar General Hospital (BGH) were periodically included in multi-centre studies Treatment and Secondary Prevention of Ischemic Coronary Events in Croatia (TASPIC-CRO) I-V. Chi-squaxed test was used to compare the frequency of risk factors and drugs recommended on discharge in patients BGH included in 1998 (TASPIC-CRO I) and 2003 (TASPIC-CRO V), and regarding the whole national sample. Results: Out of 15.520 in Croatia, 340 patients (2.2%) were treated in BGH. They had no difference in the frequency of hypertension, hyperlipidemia and diabetes, but the rate of smoking (35% vs 19% ; p<0.001) and positive familiaxy anamnesis (34% vs 10% ; p<0.001) were lower. The use of aspirin (78% vs 83% ; p=0.012), V, -blockers (33% vs 53% ; p<0.001) and statins (36% vs 46% ; p<0.001) were lover, and the use of ACE-inhibitors (59% vs 52%) ; p=0.008) were higer than in national sample. Although the frequency of hypercholesterolemia in Croatia were decreased from 1998 to 2003 (83% to 65%), in patients treated in BGH this rate were increased (67% to 84%). Compared TASPIC-CRO V (11=63) and TASPIC-CRO I (n=71) in BGH, the use of aspirin (91% vs 73% ; p=0.01), V~-blockers (45% vs 17% ; p=<0.001) and statins (70% vs 14% ; p<0.001) were increased. Conclusions: Although considerable frequency of adjustable risk factors, the use of cardiovascular medications at the time of discharge from county hospital is still suboptimal.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE